Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Medicine | 4 | 2015 | 82 | 1.100 |
Why?
|
| Clinical Competence | 5 | 2015 | 379 | 1.060 |
Why?
|
| Ultrasonography, Interventional | 3 | 2011 | 57 | 0.880 |
Why?
|
| Abscess | 4 | 2014 | 52 | 0.810 |
Why?
|
| Blood Volume | 2 | 2015 | 35 | 0.720 |
Why?
|
| Carotid Arteries | 2 | 2015 | 48 | 0.720 |
Why?
|
| Ultrasonography | 6 | 2017 | 294 | 0.700 |
Why?
|
| Internship and Residency | 4 | 2015 | 356 | 0.630 |
Why?
|
| Learning Curve | 1 | 2015 | 9 | 0.620 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2014 | 10 | 0.600 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 35 | 0.580 |
Why?
|
| Radiology | 1 | 2015 | 62 | 0.580 |
Why?
|
| Dehydration | 1 | 2014 | 13 | 0.570 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 77 | 0.560 |
Why?
|
| Fluid Therapy | 1 | 2014 | 34 | 0.550 |
Why?
|
| Point-of-Care Systems | 3 | 2017 | 64 | 0.530 |
Why?
|
| Drainage | 3 | 2012 | 86 | 0.500 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 32 | 0.450 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 19 | 0.400 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 15 | 0.380 |
Why?
|
| Optic Nerve | 1 | 2008 | 15 | 0.380 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 70 | 0.360 |
Why?
|
| Prospective Studies | 7 | 2017 | 1667 | 0.360 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 18 | 0.330 |
Why?
|
| Abdomen | 1 | 2006 | 68 | 0.330 |
Why?
|
| Emergency Service, Hospital | 3 | 2017 | 398 | 0.300 |
Why?
|
| Educational Measurement | 2 | 2015 | 132 | 0.290 |
Why?
|
| Heart Failure | 1 | 2009 | 460 | 0.280 |
Why?
|
| Education, Medical, Graduate | 3 | 2015 | 120 | 0.250 |
Why?
|
| Male | 11 | 2017 | 17193 | 0.230 |
Why?
|
| Adult | 8 | 2015 | 9831 | 0.230 |
Why?
|
| Humans | 14 | 2017 | 34019 | 0.220 |
Why?
|
| Female | 11 | 2017 | 19062 | 0.220 |
Why?
|
| Retrospective Studies | 4 | 2017 | 2634 | 0.200 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2017 | 7 | 0.180 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 7 | 0.180 |
Why?
|
| Confidence Intervals | 2 | 2014 | 251 | 0.160 |
Why?
|
| Ischemic Preconditioning, Myocardial | 3 | 2004 | 23 | 0.150 |
Why?
|
| Decision Trees | 1 | 2014 | 34 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2015 | 153 | 0.140 |
Why?
|
| Aged | 4 | 2017 | 7694 | 0.140 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 81 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 171 | 0.140 |
Why?
|
| Heart Rate | 1 | 2014 | 216 | 0.130 |
Why?
|
| Curriculum | 1 | 2015 | 303 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 789 | 0.130 |
Why?
|
| Jejunum | 2 | 2002 | 21 | 0.130 |
Why?
|
| Middle Aged | 4 | 2017 | 9903 | 0.130 |
Why?
|
| Critical Care | 1 | 2014 | 166 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2014 | 366 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2923 | 0.120 |
Why?
|
| Ischemia | 2 | 2002 | 127 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2010 | 25 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2010 | 34 | 0.110 |
Why?
|
| Young Adult | 2 | 2014 | 2267 | 0.110 |
Why?
|
| Myocardium | 2 | 2002 | 197 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 67 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1006 | 0.100 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 6 | 0.100 |
Why?
|
| Soft Tissue Infections | 1 | 2009 | 22 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2009 | 48 | 0.100 |
Why?
|
| Dyspnea | 1 | 2009 | 43 | 0.100 |
Why?
|
| Respiration | 1 | 2009 | 57 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2015 | 499 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 2555 | 0.090 |
Why?
|
| Naloxone | 3 | 2004 | 35 | 0.090 |
Why?
|
| Imino Acids | 1 | 2006 | 3 | 0.080 |
Why?
|
| Gallstones | 1 | 2006 | 17 | 0.080 |
Why?
|
| Cholecystitis | 1 | 2006 | 20 | 0.080 |
Why?
|
| Videotape Recording | 1 | 2006 | 44 | 0.080 |
Why?
|
| United States | 1 | 2015 | 4056 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 56 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 93 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 437 | 0.080 |
Why?
|
| Narcotics | 1 | 2004 | 32 | 0.070 |
Why?
|
| Apnea | 1 | 2004 | 21 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2618 | 0.070 |
Why?
|
| Heart | 2 | 2004 | 212 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 110 | 0.070 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 2002 | 2 | 0.060 |
Why?
|
| Receptors, Opioid, delta | 1 | 2002 | 4 | 0.060 |
Why?
|
| Receptors, Opioid | 1 | 2002 | 14 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2002 | 39 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 1528 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 34 | 0.060 |
Why?
|
| Rabbits | 4 | 2004 | 299 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 479 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 841 | 0.060 |
Why?
|
| Adrenergic Agents | 1 | 2017 | 3 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 20 | 0.050 |
Why?
|
| Epinephrine | 1 | 2017 | 44 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 2002 | 444 | 0.040 |
Why?
|
| Echocardiography | 1 | 2017 | 205 | 0.040 |
Why?
|
| Supine Position | 1 | 2015 | 22 | 0.040 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 4 | 0.040 |
Why?
|
| Gallbladder | 1 | 2015 | 11 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 47 | 0.040 |
Why?
|
| Registries | 1 | 2017 | 458 | 0.040 |
Why?
|
| Observer Variation | 1 | 2015 | 152 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 45 | 0.040 |
Why?
|
| Narcotic Antagonists | 2 | 2004 | 48 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 120 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 152 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 357 | 0.030 |
Why?
|
| Muscle Contraction | 2 | 2002 | 131 | 0.030 |
Why?
|
| Logistic Models | 1 | 2014 | 925 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 982 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 7 | 0.030 |
Why?
|
| Punctures | 1 | 2010 | 36 | 0.030 |
Why?
|
| Manikins | 1 | 2010 | 14 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2014 | 1355 | 0.030 |
Why?
|
| Massachusetts | 1 | 2014 | 1452 | 0.030 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 5 | 0.030 |
Why?
|
| Cellulitis | 1 | 2009 | 10 | 0.030 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 23 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 821 | 0.020 |
Why?
|
| Skin | 1 | 2009 | 229 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2737 | 0.020 |
Why?
|
| Animals | 4 | 2004 | 14099 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 1458 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 1624 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 4117 | 0.020 |
Why?
|
| Glyburide | 1 | 2002 | 5 | 0.020 |
Why?
|
| Mesentery | 1 | 2002 | 11 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 2002 | 14 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 23 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 10 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 163 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 79 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 2001 | 6 | 0.020 |
Why?
|
| Enkephalin, Methionine | 1 | 2001 | 8 | 0.020 |
Why?
|
| Hypoxia | 1 | 2002 | 63 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2001 | 77 | 0.020 |
Why?
|
| Random Allocation | 1 | 2001 | 162 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2001 | 166 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 650 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 310 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 1154 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 721 | 0.010 |
Why?
|